Breadcrumb AMCP.org Policy & Advocacy Letters, Statements & Analysis AMCP Submits Comments on FDA Draft Guidance on the Drug Manufacturer Importation Pathway AMCP Submits Comments on FDA Draft Guidance on the Drug Manufacturer Importation Pathway 2/21/20 Tweet this pagePost this page on FacebookPost this page on LinkedInEmail this pagePrint this page AMCP Submits Comments on FDA Draft Guidance on the Drug Manufacturer Importation Pathway.pdf Tweet this pagePost this page on FacebookPost this page on LinkedInEmail this pagePrint this page